ODI Pharma AB (publ) (NGM:ODI)

ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	65	35	110	84	82	68
Market Cap Growth	47.73%	-68.34%	30.91%	1.85%	21.08%	-20.36%
Enterprise Value	62	33	104	80	73	52
Last Close Price	3.54	2.18	7.20	5.50	5.40	4.46
PS Ratio	7.24	11.07	4.92	600.26	262.63	-
PB Ratio	221.82	81.70	54.76	32.54	8.87	4.17
P/TBV Ratio	221.82	81.70	54.76	32.54	8.87	4.17
EV/Sales Ratio	6.92	10.43	4.65	573.75	233.92	-
EV/EBITDA Ratio	-	-	240.49	-	-	-
EV/EBIT Ratio	-	-	242.14	-	-	-
Net Debt / Equity Ratio	-9.87	-3.49	-1.32	-2.52	-0.79	-0.90
Net Debt / EBITDA Ratio	0.72	0.27	-6.13	0.95	1.02	3.70
Net Debt / FCF Ratio	0.74	0.45	0.69	1.27	1.00	2.41
Asset Turnover	1.33	0.37	2.18	0.02	0.02	-
Inventory Turnover	-	-	-	0.77	0.34	-
Quick Ratio	1.01	0.71	1.14	1.30	6.84	26.74
Current Ratio	1.04	0.86	1.20	1.46	8.49	29.00
Return on Equity (ROE)	-1098.61%	-489.19%	-24.84%	-116.63%	-56.64%	-21.89%
Return on Assets (ROA)	-37.12%	-40.47%	2.62%	-45.57%	-32.91%	-13.13%
Return on Capital Employed (ROCE)	-1367.10%	-1283.70%	21.40%	-264.80%	-77.80%	-24.30%
Earnings Yield	-6.94%	-17.10%	-0.52%	-8.24%	-8.81%	-5.87%
FCF Yield	-	-9.53%	-3.49%	-6.10%	-8.98%	-8.93%
Buyback Yield / Dilution	-26.93%	-21.82%	0.76%	-1.69%	1.52%	-11.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.